Investor’s pick: National Bank of Greece (ADR) (NYSE:NBG), The Coca-Cola Company (NYSE:KO), Hydrogenics Corporation (NASDAQ:HYGS), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), Merck (NYSE:MRK)

National Bank of Greece (ADR) (NYSE:NBG) has a short ratio of 15.7 , which means that the counter should take 15.7 days to cover the total short interest. A high short ratio indicates a high build-up of short positions in the counter whereas a low short ratio implies that there are fewer short positions. National Bank of Greece (ADR) (NYSE:NBG) in last trading activity advanced 10.56% to close at $1.99. Company weekly performance is 0.51% while its quarterly performance stands at -36.62%. National Bank of Greece (ADR) (NYSE:NBG) is -66.72% away from its 52 week high.

The Coca-Cola Company (NYSE:KO) has been appointed official soft drink of Rugby World Cup 2015, extending its successful sponsorship of rugby’s showcase event stretching back to 1995. The Coca-Cola Company (NYSE:KO) in last trading activity moved up 2.87% to close at $41.55. Company weekly performance is -0.12% while its quarterly performance stands at 0.12%. The Coca-Cola Company (NYSE:KO) is -7.67% away from its 52 week high.

Hydrogenics Corporation (NASDAQ:HYGS) announced the delivery delay of two projects scheduled for shipment in the fourth quarter. The revenue associated with these customers, approximately $5 million in aggregate, will now be recognized in the first quarter of 2015. On last trading day Hydrogenics Corporation (NASDAQ:HYGS) advanced 9.05% to close at $12.89. Its volatility for the week is 12.16% while volatility for the month is 8.13%. HYGS’s sales growth for past 5 years was 1.50% and its EPS growth for past 5 years was 23.10%. Hydrogenics Corporation (NASDAQ:HYGS) monthly performance is -11.59%.

Deutsche Bank initiated coverage on shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) in a research report released on December 2, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $74.00 price objective on the stock. Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) has 2.20% insider ownership while its institutional ownership stands at 94.10%. In last trading activity company’s stock closed at $52.04.

Merck & Co., Inc. (NYSE:MRK) is rumored to be approaching banks to secure a 364-day loan worth $8 billion to partially finance its acquisition of Cubist Pharmaceuticals Inc (NASDAQ:CBST). On last trading day Merck & Co. Inc. (NYSE:MRK) moved up 1.46% to close at $57.63. Its volatility for the week is 2.56% while volatility for the month is 1.67%. MRK’s sales growth for past 5 years was 13.00% and its EPS growth for past 5 years was -16.50%. Merck & Co. Inc. (NYSE:MRK) monthly performance is -2.34%.

Leave a Reply

Your email address will not be published. Required fields are marked *

*